Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry

Thyroid

Volumn 23, Issue 7, 2013, Pages 817-828

  Bychkov, Andrey ^a   Saenko, Vladimir ^a   Nakashima, Masahiro ^a   Mitsutake, Norisato ^a   Rogounovitch, Tatiana ^a   Nikitski, Alyaksandr ^a   Orim, Florence ^a   Yamashita, Shunichi ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR FOXE1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CELL; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; THYROID NEOPLASMS;

EID: 84881442899     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0466     Document Type: Article

References (57)

1. Siegel R, Naishadham D, Jemal A 2012 Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Center for Cancer Control and Information Services NCC, Japan. Cancer Statistics in Japan. http://ganjoho.jp/pro/ statistics/en/table-download.html (accessed September 27, 2012).
3. DeLellis RA 2006 Pathology and genetics of thyroid carcinoma. J Surg Oncol 94:662-669
4. Nikiforov YE 2011 Molecular analysis of thyroid tumors. Mod Pathol 24(Suppl 2):S34-43
5. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
6. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19:2516-2523
7. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, Andia V, Rodriguez-Poyo P, Jara-Albarran A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Pico A, Pomares F, Gimenez G, Lopez-Mondejar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodriguez-Antona C, Gonzalez-Neira A, Matias-Guiu X, Santisteban P, Robledo M 2009 The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637
8. Matsuse M, Takahashi M, Mitsutake N, Nishihara E, Hirokawa M, Kawaguchi T, Rogounovitch T, Saenko V, Bychkov A, Suzuki K, Matsuo K, Tajima K, Miyauchi A, Yamada R, Matsuda F, Yamashita S 2011 The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48:645-648
9. Jones AM, Howarth KM, Martin L, Gorman M, Mihai R, Moss L, Auton A, Lemon C, Mehanna H, Mohan H, Clarke SE, Wadsley J, Macias E, Coatesworth A, Beasley M, Roques T, Martin C, Ryan P, Gerrard G, Power D, Bremmer C, Tomlinson I, Carvajal-Carmona LG 2012 Thyroid cancer susceptibility polymorphisms: Confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 49:158-163
10. Bullock M, Duncan EL, O'Neill C, Tacon L, Sywak M, Sidhu S, Delbridge L, Learoyd D, Robinson BG, Ludgate M, Clifton- Bligh RJ 2012 Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 97:E1814-1819
11. Chadwick BP, Obermayr F, Frischauf AM 1997 FKHL15, a new human member of the forkhead gene family located on chromosome 9q22. Genomics 41:390-396
12. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R 1997 TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 16:3185-3197
13. Trueba SS, Auge J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M, Polak M, Attie-Bitach T 2005 PAX8, TITF1, and FOXE1 gene expression patterns during human development: New insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 90:455-462
14. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, Lazarus JH, Ludgate M, Chatterjee VK 1998 Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 19:399-401
15. Sequeira M, Al-Khafaji F, Park S, Lewis MD, Wheeler MH, Chatterjee VK, Jasani B, Ludgate M 2003 Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis. Thyroid 13:927-932
16. Eichberger T, Regl G, Ikram MS, Neill GW, Philpott MP, Aberger F, Frischauf AM 2004 FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. J Invest Dermatol 122:1180-1187
17. Venza I, Visalli M, Tripodo B, De Grazia G, Loddo S, Teti D, Venza M 2010 FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma. Br J Dermatol 162: 1093-1097
18. Park E, Gong EY, Romanelli MG, Lee K 2012 Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells. Biochem Biophys Res Commun 421:532-537
19. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M 2003 Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63:3735-3742
20. Aza-Blanc P, Di Lauro R, Santisteban P 1993 Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. Mol Endocrinol 7:1297-1306
21. Civitareale D, Saiardi A, Falasca P 1994 Purification and characterization of thyroid transcription factor 2. Biochem J 304(Pt 3):981-985
22. Ortiz L, Zannini M, Di Lauro R, Santisteban P 1997 Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I. J Biol Chem 272:23334-23339
23. Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B, Ludgate M 2001 Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 11:995-1001
24. Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R 2008 Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol 21:192-200
25. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kakudo K 2006 Immunohistochemical analysis of thyroidspecific transcription factors in thyroid tumors. Pathol Int 56:240-245
26. Sobin LH, Gospodarowicz MK, Wittekind C 2009 TNM classification of malignant tumours. 7th ed. Wiley-Blackwell, Oxford, U.K.
27. DeLellis RA 2004 Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon
28. King J, Thatcher N, Pickering C, Hasleton P 2006 Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: A systematic review of published reports. Histopathology 49:561-568
29. Hanna-Morris A, Badvie S, Cohen P, McCullough T, Andreyev HJ, Allen-Mersh TG 2009 Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. J Clin Pathol 62:325-330
30. Cho Mar K, Eimoto T, Nagaya S, Tateyama H 2006 Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48:801-807
31. Mehrotra P, Gonzalez MA, Johnson SJ, Coleman N, Wilson JA, Davies BR, Lennard TW 2006 Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope 116:1434-1438
32. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T 1998 Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704
33. El-Gendi S, Al-Gendi A 2011 Assessment of tumor budding in colorectal carcinoma: Correlation with beta-catenin nuclear expression. J Egypt Natl Canc Inst 23:1-9
34. Jabs WJ, Busse M, Kruger S, Jocham D, Steinhoff J, Doehn C 2005 Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 68:2103-2110
35. Hong SW, Kang YK, Lee B, Lee WY, Jang YG, Paik IW, Lee H 2011 Matrix metalloproteinase-2 and-7 expression in colorectal cancer. J Korean Soc Coloproctol 27:133-139
36. Johansson M, Brannstrom T, Bergenheim AT, Henriksson R 2002 Spatial expression of VEGF-A in human glioma. J Neurooncol 59:1-6
37. Scarpino S, Stoppacciaro A, Ballerini F, Marchesi M, Prat M, Stella MC, Sozzani S, Allavena P, Mantovani A, Ruco LP 2000 Papillary carcinoma of the thyroid: Hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol 156:831-837
38. Ugolini C, Basolo F, Proietti A, Vitti P, Elisei R, Miccoli P, Toniolo A 2007 Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid 17:389-393
39. Proietti A, Ugolini C, Melillo RM, Crisman G, Elisei R, Santoro M, Minuto M, Vitti P, Miccoli P, Basolo F 2011 Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: Correlation with clinical and pathological parameters. Thyroid 21:1209-1215
40. Kojc N, Zidar N, Vodopivec B, Gale N 2005 Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Hum Pathol 36:16-21
41. Qian BZ, Pollard JW 2010 Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51
42. Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, Hiai H, Toyokuni S 1997 Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: Independence of tubular necrosis and sulfhydryl depletion. Lab Invest 77:145-155
43. Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham AH 2006 Loss of expression and nuclear/ cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: Relationship with estrogen receptors and HIF-1alpha expression. Mod Pathol 19:9-16
44. Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H, Ito M, Abrosimov A, Lushnikov E, Sekine I, Yamashita S 2005 Cyclin D1 overexpression in thyroid papillary microcarcinoma: Its association with tumour size and aberrant beta-catenin expression. Histopathology 47:248-256
45. Cheuk W, Chan JK 2004 Subcellular localization of immunohistochemical signals: Knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains. Int J Surg Pathol 12:185-206
46. Brancaccio A, Minichiello A, Grachtchouk M, Antonini D, Sheng H, Parlato R, Dathan N, Dlugosz AA, Missero C 2004 Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. Hum Mol Genet 13:2595-2606
47. Venza I, Visalli M, Parrillo L, De Felice M, Teti D, Venza M 2011 MSX1 and TGF-beta3 are novel target genes functionally regulated by FOXE1. Hum Mol Genet 20:1016-1025
48. Choi JH, Kim BK, Kim JK, Lee HY, Park JK, Yoon SK 2011 Downregulation of Foxe1 by HR suppresses Msx1 expression in the hair follicles of Hr(Hp) mice. BMB Rep 44:478- 483
49. Xu X, Ding H, Rao G, Arora S, Saclarides CP, Esparaz J, Gattuso P, Solorzano CC, Prinz RA 2012 Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer 19:167-179
50. Sastre-Perona A, Santisteban P 2012 Role of the wnt pathway in thyroid cancer. Front Endocrinol (Lausanne) 3:31
51. Baba K, Ishibashi M, Kaida H, Fujii T, Hiromatsu Y, Kawahara A, Kage M, Hayabuchi N 2011 Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen- activated protein kinase in papillary thyroid cancer patients. Jpn J Radiol 29:533-539
52. Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS 2007 High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 17:1031-1038
53. Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N 2007 Targeting BRAFV600E in thyroid carcinoma: Therapeutic implications. Mol Cancer Ther 6:1070-1078
54. Zuo H, Nakamura Y, Yasuoka H, Zhang P, Nakamura M, Mori I, Miyauchi A, Kakudo K 2007 Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma. Pathol Int 57:12-20
55. Shin E, Hong SW, Kim SH, Yang WI 2004 Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p- JNK and p-AKT) in papillary thyroid carcinomas. Yonsei Med J 45:306-313
56. Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW, Chung JH 2007 USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J 54:275-285
57. Kallel R, Belguith-Maalej S, Akdi A, Mnif M, Charfeddine I, Galofre P, Ghorbel A, Abid M, Marcos R, Ayadi H, Velazquez A, Hadj Kacem H 2010 Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: New insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomark 8:43-51